Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries. Between ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The HeartMate II Left Ventricular ...

Fineheart SA will soon begin a first-in-human study of Flowmaker, its fully implantable left ventricular assist device, in France, after receiving authorization from the French National Agency for the ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced it has received a breakthrough device designation from the FDA for its fully implantable ...

INDIANAPOLIS — Sometimes treatments, medications and even a transplant won’t do the trick for patients with heart failure. They are left with only one option: getting a rare heart device implanted in ...

There is no clearly established strategy for the treatment of a patient with cardiomyopathy and a symptomatic aneurysm of the thoracic aorta. We report the successful use of an approach combining ...

Mechanical circulatory support systems for the treatment of end-stage heart failure are now available for a wide variety of clinical situations and support times. Extracorporeal membrane oxygenation ...

Austin, TX, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Left Ventricular Assist Devices Market Size, Trends and Insights By Product (Left ...

Every year, around 50,000 people in the United States experience cardiogenic shock - a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood ...

Connex Biomedical Inc. applied for patent protection for a transcardiac access port affixed and retained post-procedure on the cardiac muscle, such as the ventricular myocardium, and an access port ...